Determinants of omalizumab dose-related efficacy in oral immunotherapy: evidence from a cohort of 181 patients.

Capsule summaryUsing a large cohort of food allergic patients undergoing oral immunotherapy, the dose-related efficacy of omalizumab is shown to be dependent on its dosage per weight and independent of total IgE levels.

Source: Journal of Allergy and Clinical Immunology - September 23, 2020 Category: Allergy & Immunology Authors: Pauline Azzano, Maxime Paquin, Alexandra Langlois, Charles Morin, Guy Parizeault, Jonathan Lacombe-Barrios, Kathryn Samaan, Fran çois Graham, Louis Paradis, Anne Des Roches, Philippe Begin Source Type: research